271 related articles for article (PubMed ID: 1591725)
1. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
2. Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.
Basu A; Kozikowski AP; Sato K; Lazo JS
Cancer Res; 1991 May; 51(10):2511-4. PubMed ID: 2021930
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
Basu A; Weixel K; Saijo N
Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
Mohanty S; Huang J; Basu A
Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
[TBL] [Abstract][Full Text] [Related]
5. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
6. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
7. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL; Bradshaw TD; Gescher A; Pettit GR
Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
10. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
11. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
12. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
13. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II).
Basu A; Teicher BA; Lazo JS
J Biol Chem; 1990 May; 265(15):8451-7. PubMed ID: 2341390
[TBL] [Abstract][Full Text] [Related]
14. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
15. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.
Pasti G; Rivedal E; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1988 Jan; 48(2):447-51. PubMed ID: 3422054
[TBL] [Abstract][Full Text] [Related]
16. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C.
Basu A; Akkaraju GR
Biochemistry; 1999 Apr; 38(14):4245-51. PubMed ID: 10194341
[TBL] [Abstract][Full Text] [Related]
17. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
Gschwend JE; Fair WR; Powell CT
Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
[TBL] [Abstract][Full Text] [Related]
18. Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.
Warren BS; Kamano Y; Pettit GR; Blumberg PM
Cancer Res; 1988 Nov; 48(21):5984-8. PubMed ID: 3167850
[TBL] [Abstract][Full Text] [Related]
19. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
Dell'Aquila ML; Nguyen HT; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1987 Nov; 47(22):6006-9. PubMed ID: 3478136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
